Price $13.40 |
Market Cap
814.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.74
|
P/S
504.64
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-54.2K
|
FCF
-0.9
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-33.40%
|
ROI
-38.20%
|
|
ROA
-30.80%
|
EPS Growth
7.40%
|
Current Ratio
19.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Esperion Therapeutics Inc (ESPR) | $38.41 | - | - | 1.04B | Strong Buy |
| TearLab Corp (TEAR) | $0.07 | - | - | 900K | Strong Buy |
| CVS Health Corp (CVS) | $60.28 | - | 3.60% | 71.93B | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.57 | - | - | 28.4M | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.80 | - | - | 43.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
